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Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit COX enzyme activity, a significant mechanism of action of NSAIDs. Inflammation is associated with increasing cancer incidence.  Recent pre-clinical and clinical studies have 
shown that NSAID treatment could cause an anti-tumour effect in cancers. Such studies are lengthy and expensive.  The 
present study, however, examined DNA damage in the Comet and micronucleus assays in peripheral blood lymphocytes 
of patients with respiratory diseases and healthy individuals using the nanoparticle (NP) and bulk versions of the NSAIDs, 
aspirin and ibuprofen. Lymphocytes are suitable surrogate cells for cancers and other disease states.  DNA damage decreased 
in lymphocytes from healthy individuals, asthma, COPD and lung cancer patient groups after treatment with aspirin nano 
(ASP-N) and ibuprofen nano (IBU-N) compared to their bulk version in both assays. However, when ASP-N was compared to 
untreated lymphocytes in all groups in the Comet assay, DNA damage significantly decreased in all groups, except the asthma 
group. When IBU-N was compared to untreated lymphocytes, in healthy individuals and the lung cancer group, DNA damage 
decreased, but increased in asthma and COPD groups. Similarly, micronuclei (MNi) increased after ASP-N and IBU-N in the 
healthy individual and lung cancer groups, and decreased in asthma and COPD groups. Furthermore, lymphocytes responses 
after IBU-N and ibuprofen bulk were investigated by the physiological patch-clamp technique.  Patch-clamp recordings 
demonstrated that IBU-N inhibited ion channel activity by 20%. This molecular epidemiology approach mirrors pre-clinical 
and clinical findings, and provides further information using nanoparticles.
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